Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C+ NK cells to target myeloid leukemia
Chiu, Emily, Felices, Martin, Cichocki, Frank, Davis, Zachary, Wang, Hongbo, Tuninga, Katie, Vallera, Daniel A., Lee, Tom, Bjordahl, Ryan, Malmberg, Karl Johan, Valamehr, Bahram, Miller, Jeffrey S.
Published in Molecular therapy (01.12.2021)
Published in Molecular therapy (01.12.2021)
Get full text
Journal Article
161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS
Sarhan, Dhifaf, Brandt, Ludwig, Felices, Martin, Guldevall, Karolin, Lenvik, Todd, Hinderlie, Peter, Curtsinger, Julie, Warlick, Erica, Spellman, Stephen R., Blazar, Bruce R., Weisdorf, Daniel J., Cooley, Sarah, Vallera, Daniel A., Önfelt, Björn, Miller, Jeffrey S.
Published in Blood advances (26.06.2018)
Published in Blood advances (26.06.2018)
Get full text
Journal Article
Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin
Oh, Felix, Todhunter, Deborah, Taras, Elizabeth, Vallera, Daniel A, Borgatti, Antonella
Published in Clinical pharmacology: advances and applications (01.01.2018)
Published in Clinical pharmacology: advances and applications (01.01.2018)
Get full text
Journal Article
Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts
BLAZAR, B. R, TAYLOR, P. A, PANOSKATSIS-MORTARI, A, GRAY, G. S, VALLERA, D. A
Published in Blood (01.05.1995)
Published in Blood (01.05.1995)
Get full text
Journal Article
A Bispecific Recombinant Immunotoxin, DT2219, Targeting Human CD19 and CD22 Receptors in a Mouse Xenograft Model of B-Cell Leukemia/Lymphoma
VALLERA, Daniel A, TODHUNTER, Deborah A, KUROKI, David W, YANQUN SHU, SICHENEDER, Andy, HUA CHEN
Published in Clinical cancer research (15.05.2005)
Published in Clinical cancer research (15.05.2005)
Get full text
Journal Article
Targeting Urokinase-Type Plasminogen Activator Receptor on Human Glioblastoma Tumors With Diphtheria Toxin Fusion Protein DTAT
Vallera, Daniel A., Li, Chunbin, Jin, Ni, Panoskaltsis-Mortari, Angela, Hall, Walter A.
Published in JNCI : Journal of the National Cancer Institute (17.04.2002)
Published in JNCI : Journal of the National Cancer Institute (17.04.2002)
Get full text
Journal Article
Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice
Murphy, W J, Welniak, L A, Taub, D D, Wiltrout, R H, Taylor, P A, Vallera, D A, Kopf, M, Young, H, Longo, D L, Blazar, B R
Published in The Journal of clinical investigation (01.11.1998)
Published in The Journal of clinical investigation (01.11.1998)
Get full text
Journal Article
A bispecific immunotoxin (DTAT13) targeting human IL‐13 receptor (IL‐13R) and urokinase‐type plasminogen activator receptor (uPAR) in a mouse xenograft model
Todhunter, Deborah A., Hall, Walter A., Rustamzadeh, Edward, Shu, Yanqun, Doumbia, Sekou O., Vallera, Daniel A.
Published in Protein engineering, design and selection (01.02.2004)
Published in Protein engineering, design and selection (01.02.2004)
Get full text
Journal Article
Opposing Roles of CD28:B7 and CTLA-4:B7 Pathways in Regulating In Vivo Alloresponses in Murine Recipients of MHC Disparate T Cells
Blazar, Bruce R, Taylor, Patricia A, Panoskaltsis-Mortari, Angela, Sharpe, Arlene H, Vallera, Daniel A
Published in The Journal of immunology (1950) (01.06.1999)
Published in The Journal of immunology (1950) (01.06.1999)
Get full text
Journal Article
Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation
Blazar, B R, Taylor, P A, Panoskaltsis-Mortari, A, Buhlman, J, Xu, J, Flavell, R A, Korngold, R, Noelle, R, Vallera, D A
Published in The Journal of immunology (1950) (01.01.1997)
Published in The Journal of immunology (1950) (01.01.1997)
Get full text
Journal Article
CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses
Blazar, B R, Taylor, P A, Noelle, R J, Vallera, D A
Published in The Journal of clinical investigation (01.08.1998)
Published in The Journal of clinical investigation (01.08.1998)
Get full text
Journal Article
In Vivo Blockade of CD28/CTLA4: B7/BB1 Interaction With CTLA4-Ig Reduces Lethal Murine Graft-Versus-Host Disease Across the Major Histocompatibility Complex Barrier in Mice
Blazar, Bruce R., Taylor, Patricia A., Linsley, Peter S., Vallera, Daniel A.
Published in Blood (15.06.1994)
Published in Blood (15.06.1994)
Get full text
Journal Article
Engraftment of Severe Combined Immune Deficient Mice Receiving Allogeneic Bone Marrow Via In Utero or Postnatal Transfer
Blazar, Bruce R., Taylor, Patricia A., McElmurry, Ron, Tian, Lina, Panoskaltsis-Mortari, Angela, Lam, Sylvia, Lees, Chris, Waldschmidt, Thomas, Vallera, Daniel A.
Published in Blood (15.11.1998)
Published in Blood (15.11.1998)
Get full text
Journal Article
Rapamycin Inhibits the Generation of Graft-Versus-Host Disease- and Graft-Versus-Leukemia-Causing T Cells by Interfering with the Production of Th1 or Th1 Cytotoxic Cytokines
Blazar, Bruce R, Taylor, Patricia A, Panoskaltsis-Mortari, Angela, Vallera, Daniel A
Published in The Journal of immunology (1950) (01.06.1998)
Published in The Journal of immunology (1950) (01.06.1998)
Get full text
Journal Article